Neuproscan

About Neuproscan

Neuproscan is a pioneering AI platform that detects early pre-clinical Alzheimer's using MRI scans. It empowers healthcare providers with high accuracy predictions, substantially improving early diagnosis. Patients can plan for their future effectively, enhancing their quality of life while reducing the reliance on costly PET scans.

Neuproscan offers various pricing tiers targeting both individual practices and large hospitals. While specific prices may vary, users can generally expect cost-effective options that enable high-value predictive analytics for Alzheimer’s detection. Discounts may apply for multiple subscriptions, making upgrades beneficial for advanced features and better patient outcomes.

Neuproscan features an intuitive user interface designed for ease of navigation, ensuring a seamless user experience. The layout streamlines access to essential tools and predictive analytics, enhancing usability for healthcare professionals and institutions. This focus on design makes Neuproscan accessible to users of all technical backgrounds.

How Neuproscan works

Users begin with onboarding by submitting MRI scans into Neuproscan's AI platform. Once scanned, the platform analyzes the data to predict the likelihood of developing Alzheimer's in the coming years. The interface guides healthcare providers through the process, from interpretation of results to implementing clinical decisions, ensuring user-friendliness and accessibility.

Key Features for Neuproscan

AI-Powered Alzheimer’s Prediction

Neuproscan’s AI-Powered Alzheimer’s Prediction feature allows healthcare providers to assess the likelihood of Alzheimer’s development from MRI scans. With an 88% accuracy rate in identifying at-risk patients, this innovative tool aids in proactive healthcare planning and improves diagnostic outcomes.

Customizable AI Model Development

Neuproscan offers a unique feature for Customizable AI Model Development, enabling users to tailor their predictive models to specific patient datasets. This flexibility enhances diagnostic precision and empowers healthcare professionals to optimize their approach while utilizing the full potential of MRI data.

Multi-Slice MRI Analysis

The Multi-Slice MRI Analysis capability allows Neuproscan to efficiently utilize up to nine MRI slices for predictive modeling. This comprehensive examination of critical views enhances diagnostic accuracy, showcasing Neuproscan's strength in processing complex MRI data to identify early Alzheimer’s symptoms.